Leibsohn S, d'Ablaing G, Mishell D R, Schlaerth J B
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Women's Hospital, Los Angeles 90033.
Am J Obstet Gynecol. 1990 Apr;162(4):968-74; discussion 974-6. doi: 10.1016/0002-9378(90)91298-q.
The incidence of leiomyosarcoma in uterine leiomyomas is estimated to be between 0.13 to 0.29%. However, the exact incidence of leiomyosarcoma in uteri removed with a preoperative diagnosis of benign uterine leiomyomas has not been previously reported. Between 1983 and 1988, a total of 1432 patients in Women's Hospital, a self-referred indigent population, had a hysterectomy planned because of abnormal uterine bleeding or abdominal pain associated with the presence of uterine leiomyomas, or because of a pelvic mass thought to be uterine leiomyoma of sufficient size or character to warrant surgical exploration. The ages of these women ranged from 36 to 62 years and the presence of leiomyosarcoma in the hysterectomy specimens increased steadily from the fourth to seventh decades of age (0.2%, 0.9%, 1.4%, and 1.7%, respectively). Preoperative histologic examination of the endometrium was performed in eight patients. Three of the eight patients had a preoperative tissue diagnosis of leiomyosarcoma that was clinically confined to the uterus. After the hysterectomy in the 1429 patients with presumed benign disease, histologic diagnosis of leiomyosarcoma was made in seven (0.49%). There was no evidence of malignancy in the endometrial sampling of any of these seven patients and the diagnosis was suspected intraoperatively in only three. Preoperative uterine size ranged from 8 to 20 weeks' gestational size and postoperative uterine weight ranged from 120 to 1100 gm. Seven of the 10 patients had symptoms of abnormal uterine bleeding. Between the ages of 40 and 60 years, 1% (8 of 817) of women with presumed uterine leiomyomas producing symptoms that necessitated hysterectomy in this series had leiomyosarcoma diagnosis postoperatively. Such treatments as gonadotropin-releasing hormone agonists, endometrial ablation, myomectomy by hysteroscopy or laparotomy instead of hysterectomy in such women could delay the diagnosis and definitive treatment of leiomyosarcoma.
子宫平滑肌瘤中平滑肌肉瘤的发生率估计在0.13%至0.29%之间。然而,术前诊断为良性子宫平滑肌瘤而切除的子宫中平滑肌肉瘤的确切发生率此前尚未见报道。1983年至1988年间,在一所妇女医院,共有1432名自行前来就诊的贫困患者计划接受子宫切除术,原因是子宫平滑肌瘤伴有异常子宫出血或腹痛,或者是因为盆腔肿块被认为是子宫平滑肌瘤,其大小或特征足以进行手术探查。这些女性的年龄在36岁至62岁之间,子宫切除标本中平滑肌肉瘤的发生率从40岁至70岁稳步上升(分别为0.2%、0.9%、1.4%和1.7%)。对8名患者进行了术前子宫内膜组织学检查。这8名患者中有3名术前组织诊断为平滑肌肉瘤,临床局限于子宫。在1429例推测为良性疾病的患者子宫切除术后,7例(0.49%)被组织学诊断为平滑肌肉瘤。这7例患者的子宫内膜取样均无恶性证据,仅3例术中怀疑有恶性病变。术前子宫大小相当于妊娠8至20周,术后子宫重量在120至1100克之间。10例患者中有7例有异常子宫出血症状。在本系列中,年龄在40岁至60岁之间、因推测为子宫平滑肌瘤出现症状而需要进行子宫切除术的女性中,1%(817例中的8例)术后被诊断为平滑肌肉瘤。对于这类女性,使用促性腺激素释放激素激动剂、子宫内膜消融、宫腔镜或剖腹手术子宫肌瘤切除术而非子宫切除术等治疗方法可能会延迟平滑肌肉瘤的诊断和确定性治疗。